Psychiatry

ERG has conducted 600+ clinical studies in schizophrenia and depression.

1,800+

Psychiatry Studies

10

sites with psychiatric expertise

ERG was founded with a focus on debilitating mental health issues—optimizing our investigational sites and patient recruitment strategies to advance important therapies and helping bring dozens of much-needed medicines to market. We stand ready to assist you with your development needs.

Demonstrated Expertise in Key Indications

ADHD
Anxiety Disorders
Bipolar Disorder
Eating Disorders
Depressive Disorders
Obsessive Compulsive Disorder
Post-Traumatic Stress Disorder
Schizoaffective Disorder
Schizophrenia

Industry-Leading Psychiatric Expertise

ERG staff is headed by industry leaders in all aspects of psychiatry. Our clinical raters are certified by industry-recognized psychiatric rating experts, with senior team members bringing more than 20 years of specialized experience to the protocol. Raters provide consistency across studies. Critically, both raters and site staff receive extensive training on mitigating placebo response; training that augments sponsor-provided instruction.

In a recent rescue study of a schizophrenia therapy. ERG completed study start-up (contracting, regulatory and site initiation) in 48 hours—and was the top-enrolling site in the study.

Specialized Resources for Psychiatric Research Studies

ERG sites have access to a full suite of neuroimaging for psychiatric studies, including magnetic resonance imaging (MRI), and positron emission tomography (PET) scans. ERG has expertise conducting electroencephalography/quantitative electroencephalography (EEG EEG/qEEG) studies in psychiatric subjects, as well as other specialized testing such as ophthalmologic exams, gynecological procedures, and surgical implants.

Onsite staff prepare investigational products for all routes of administration, including compounding, encapsulation, and IV infusion. Sites engage in regular mock dosing to ensure that all time points are met, including pharmacokinetics (PK).

We complement our specialized equipment and staff expertise with rigorous quality reviews by full-time quality assurance and quality control staff to ensure optimal outcomes for your study—and ample inpatient beds to accommodate complex study designs and provide the flexibility to separate populations

The target patient population for psychiatric clinical trials is often misdiagnosed—or even undiagnosed—making these trials challenging to recruit, manage and assess. Sponsors then frequently seek very specific traits, from age and gender to BMI or symptomatology. ERG’s signature patient strategies include sophisticated patient recruitment and retention practices deployed across the entire site network. We begin with large patient databases and local partnerships, then carefully prescreen, screen and enroll to gather the optimal patient cohort for your trial.

Get in Touch

ERG’s mission is to provide the highest quality clinical trial execution across all clinical research phases to help sponsors.